J&J | JNJ - Stock



J&J reported $12.66B in Stock for its fiscal quarter ending in March of 2025.


Stock Change Date
AbbVie USD 4.53B 345M Mar/2025
Abbott USD 6.95B 315M Jun/2025
Amgen USD 6.58B 146M Jun/2025
AstraZeneca USD 6.47B 583M Jun/2025
Baxter International USD 2.17B 124M Mar/2025
Bayer EUR 12.11B 576M Jun/2025
Becton, Dickinson and Co. USD 3.95B 226M Jun/2025
Biogen USD 2.27B 400K Jun/2025
Boston Scientific USD 2.87B 57M Mar/2025
Bristol-Myers Squibb USD 2.74B 71M Jun/2025
CONMED USD 362.25M 7.57M Jun/2025
Cooper Companies USD 881M 700K Jul/2025
Dexcom USD 570.7M 32.5M Jun/2025
Edwards Lifesciences USD 1.11B 27.2M Mar/2025
Eli Lilly USD 11.01B 1.7B Jun/2025
Gilead Sciences USD 1.83B 66M Jun/2025
GlaxoSmithKline GBP 6.07B 72M Jun/2025
Globus Medical USD 772.13M 108.53M Jun/2025
Hologic USD 713.7M 3M Jun/2025
Insulet USD 446.9M 6.1M Jun/2025
Integra LifeSciences USD 465.13M 19.71M Jun/2025
Intuitive Surgical USD 1.67B 113.4M Jun/2025
J&J USD 12.66B 215M Mar/2025
Medtronic USD 5.48B 134M Apr/2025
Merck USD 6.6B 405M Jun/2025
Merit Medical Systems USD 323.31M 5.37M Jun/2025
Novartis USD 6.31B 478M Jun/2025
Pfizer USD 11.67B 817M Jun/2025
Regeneron Pharmaceuticals USD 3.21B 760.7M Jun/2025
Roche Holding CHF 7.61B 339M Dec/2024
Sanofi EUR 9.62B 12.23B Jun/2025
Stryker USD 5.29B 184M Jun/2025
Tandem Diabetes Care USD 142.57M 1.41M Jun/2025
Teva Pharmaceutical Industries USD 3.5B 250M Jun/2025
Vertex Pharmaceuticals USD 1.5B 139.6M Jun/2025
Zimmer Biomet Holdings USD 2.45B 210M Jun/2025
Zoetis USD 2.44B 74M Jun/2025